A disorder of galactosylceramide metabolism. Clinical features include neurologic regression around age 3 months, loss of spontaneous movements, hyporeflexia, generalized brain atrophy, and diffuse white matter dysmyelination.

Name Development Level Target Family
Name Description
TCRDv4.6.9
UniProt Disease